Serum Differentially Alters the Antifungal Properties of Echinocandin Drugs
Author(s) -
Padmaja Paderu,
Guillermo GarcíaEffrón,
Sergey Balashov,
Gilles Delmas,
Steven Park,
David S. Perlin
Publication year - 2007
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.01536-06
Subject(s) - echinocandin , anidulafungin , micafungin , caspofungin , echinocandins , pharmacology , antifungal , antifungal drug , microbiology and biotechnology , drug , biology , medicine , fluconazole
Antifungal efficacies of the echinocandin drugs caspofungin, micafungin, and anidulafungin were reduced significantly in the presence of 50% human serum, which yielded nearly equivalent MICs or minimum effective concentrations against diverse Candida spp. and Aspergillus spp. Consistent with a direct drug interaction, serum decreased the sensitivity of glucan synthase to echinocandin drugs.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom